OLMA

Conviction 20HealthcareScan · Thu, Sep 24, 2026

Olema Pharmaceuticals, Inc. (OLMA) closed at $9.03 (+2.27%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 33, RS Rating 95, -74.8% from its 52-week high, -64.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

OLMA$9.03+2.27%

ResistanceSupportVol 14Insider sell

Vol MA14 1.43M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Olema Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.olema.com ↗

Price9.03

Change+2.27%

Gap-1.42%

Rel volume2.35×

Avg volume1.22M

Avg $ vol12.18M

SMA 2010.16

SMA 5010.81

SMA 20016.74

Price vs 50-16.50%

Price vs 200-46.05%

MA stackbearish

50/200 cross—

Supertrenddown · 10.64

RSI (14)33

MACD hist-0.11

MACD crossbear · 8d

Stoch %K / %D17 / 11

ADX (14)17

+DI / −DI14 / 26

RSI divergence—

MACD divergence—

ATR %6.34%

ADR %5.38%

52w high35.83

52w low7.77

From 52w high-74.80%

Above 52w low+16.22%

New 52w highNo

SqueezeOff

Bollinger width23.11%

%B0.02

Donchian pos16.67%

Donchian high11.18

Donchian low8.60

AVWAP (52w high)16.62

vs AVWAP high-45.68%

AVWAP (52w low)18.75

vs AVWAP low-51.83%

OBV trendFlat

Chaikin MF (20)-0.11

Today vs 20d2.35×

Avg vol (14d)1.43M

Avg vol (20d)1.22M

Avg $ vol (20d)12.18M

Market cap790.1M

RS Rating95 / 99

RS 3m (vs SPY)-25.49%

RS 6m (vs SPY)-53.09%

RS line new highNo

Trend template0/8

Technical rank9.3

1 week-8.79%

1 month-17.23%

3 months-21.00%

6 months-36.27%

1 year+2.73%

YTD-64.28%

P/E-4.86

P/B1.83

P/S—

P/FCF-5.38

EPS-1.87

Div yield—

ROE-37.73%

ROA-33.39%

Debt/Eq—

Current8.86

EV/EBITDA-4.16

Gross margin—

Net margin—

Rev growth—

EPS growth-25.47%

Price target33.17

Target upside267.33%

Analyst ratingBuy

Institutional128.63%

Ent. value741.5M

Revenue—

Net income-63.2M

Gross profit—

Free cash flow-146.88M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out87.35M

Employees137

ListedThu, Nov 19, 2020

Free float63.44M

Float %80.7%

Short interest15.66M

Days to cover18.5d

Short volume48.2%

Squeeze score85 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.61 vs −$0.53

Last surprise-15.1% miss

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank9.3 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance11.79

Support9.57

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OLMA

All disclosures →

No recent disclosed trades by Congress in OLMA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OLMA · open-market 2 sells

Insider	Side	Shares	Value	Traded	Filed
O'Byrne Jason CHIEF FINANCIAL OFFICER · Stock Option (Right to Buy) · 2026-09-01	Grant	650K	—	2026-09-01	2026-09-02
Harmon Cyrus Director · Common Stock · 2026-07-24	Sell	12.5K	$146K	2026-07-24	2026-07-27
Harmon Cyrus Director · Common Stock · 2026-07-23	Sell	12.5K	$145K	2026-07-23	2026-07-27
Raman Prakash Director · Stock Option (Right to Buy) · 2026-04-28	Grant	24.15K	$0	2026-04-28	2026-04-29
Raman Prakash Director · Stock Option (Right to Buy) · 2026-04-28	Grant	2.91K	$0	2026-04-28	2026-04-29

SEC filings

EDGAR filings in OLMA · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.